Pawłowska, A.; Kwiatkowska, A.; Suszczyk, D.; Chudzik, A.; Tarkowski, R.; Barczyński, B.; Kotarski, J.; Wertel, I.
Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in Ovarian Cancer Patients. Int. J. Mol. Sci. 2021, 22, 11563.
https://doi.org/10.3390/ijms222111563
AMA Style
Pawłowska A, Kwiatkowska A, Suszczyk D, Chudzik A, Tarkowski R, Barczyński B, Kotarski J, Wertel I.
Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in Ovarian Cancer Patients. International Journal of Molecular Sciences. 2021; 22(21):11563.
https://doi.org/10.3390/ijms222111563
Chicago/Turabian Style
Pawłowska, Anna, Agnieszka Kwiatkowska, Dorota Suszczyk, Agata Chudzik, Rafał Tarkowski, Bartłomiej Barczyński, Jan Kotarski, and Iwona Wertel.
2021. "Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in Ovarian Cancer Patients" International Journal of Molecular Sciences 22, no. 21: 11563.
https://doi.org/10.3390/ijms222111563
APA Style
Pawłowska, A., Kwiatkowska, A., Suszczyk, D., Chudzik, A., Tarkowski, R., Barczyński, B., Kotarski, J., & Wertel, I.
(2021). Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in Ovarian Cancer Patients. International Journal of Molecular Sciences, 22(21), 11563.
https://doi.org/10.3390/ijms222111563